Docket Management
Docket: 02N-0466 - Randomized Dose Response Study of Dryvax in Children Ages 2 to 5
Comment Number: EC -49

Accepted - Volume 3

Comment Record
Commentor Mrs. Monte Kay Frederick Date/Time 2002-11-01 16:02:00
Organization Texas Dept. of Health
Category Health Professional

Comments for FDA General
Questions
1. General Comments I agree the study to test the best children's vaccine for smallpox prevention should be performed under FDA guidelines in a very controlled setting.




EC -49